{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:56:58Z","timestamp":1794916618289,"version":"4.9.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lymphedema is an edematous condition that afflicts the postmastectomy breast cancer population, with diminished quality of life with substantial financial costs. The factors predictive of postmastectomy lymphedema development in breast cancer patients are unknown. The objective was to evaluate the trends over time in lymphedema development and the risk factors predictive of lymphedema-related events within 2 years of mastectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using the New York Statewide Planning and Research Cooperative System multicenter deidentified database from 2010 to 2016, a total of 65,543 breast cancer postmastectomy female patients (mean age, 59 \u00b1 20 years) were identified across 177 facilities. The breast cancer patients were followed for any 2-year postmastectomy lymphedema-related events. A multivariable model identified predictors of 2-year lymphedema using eligible variables involving demographics, comorbidities, and complications. Elixhauser score was defined as a comorbidity index based on <jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic> codes used in hospital settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, 5.2% (n = 3409) of the breast cancer postmastectomy patients experienced a lymphedema-related event within 2 years of initial surgery. Over time, 2-year postmastectomy lymphedema rates have more than doubled from 4.62% in 2010 to 9.75% in 2016 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Two-year postmastectomy lymphedema rates varied significantly by mastectomy procedure type: 5.69% of the mastectomy-only procedures, 5.96% of the mastectomies with lymph node biopsies, and 7.83% of the mastectomies with lymph node dissections (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). Full mastectomies had a greater 2-year lymphedema rate of 7.31% when compared with partial mastectomies with 2.79% (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). The top predictive risk factors for a lymphedema-related event included higher Elixhauser score, prolonged hospitalization for mastectomy, more recent mastectomy procedure, obesity, younger age, non-Asian race, Medicaid insurance, and hypertension (all <jats:italic toggle=\"yes\">P<\/jats:italic>'s &lt; 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although more recent postmastectomy lymphedema rates may not be as high as historical estimates, the 2-year postmastectomy lymphedema rates have more than doubled from 2010 to 2016 requiring further elucidation as well as continued focus on treatment. Furthermore, risk factors were identified that predispose postmastectomy breast cancer patients to developing lymphedema. Given these findings, perioperative screening seems warranted to proactively identify, educate, and monitor postmastectomy patients at greatest risk of future lymphedema development.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000003107","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T23:05:09Z","timestamp":1645225509000},"page":"S239-S245","source":"Crossref","is-referenced-by-count":16,"title":["Risk Factors Associated With Postmastectomy Breast Cancer Lymphedema"],"prefix":"10.1097","volume":"88","author":[{"given":"Annet S.","family":"Kuruvilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar R.","family":"Mulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohaib M.","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmehar K.","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond M.","family":"Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Tannous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Laurie W.","family":"Shroyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230923","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jso.24068","article-title":"The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients","volume":"112","year":"2015","journal-title":"J Surg Oncol"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bjps.2018.01.012","article-title":"Breast reconstruction and risk of arm lymphedema development: a meta-analysis","volume":"71","year":"2018","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"bib3-20230923","first-page":"32","article-title":"Risk factors for lymphedema of the arm after mastectomy for breast cancer [in French]","volume":"44","year":"1999","journal-title":"Dakar Med"},{"key":"bib4-20230923","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","year":"2016","journal-title":"Breast"},{"key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","year":"2014","journal-title":"Int J Surg"},{"key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","year":"1998","journal-title":"Med Care"},{"key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12282-018-0830-3","article-title":"The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study","volume":"25","year":"2018","journal-title":"Breast Cancer"},{"key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000345459","article-title":"Risk factors associated with lymphedema among postmenopausal breast cancer survivors after radical mastectomy and axillary dissection in China","volume":"7","year":"2012","journal-title":"Breast Care (Basel)"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5152\/tjbh.2016.3357","article-title":"Early diagnosis of lymphedema after breast cancer treatment: bio-impedance spectroscopy","volume":"13","year":"2017","journal-title":"J Breast Health"},{"key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/lrb.2018.0033","article-title":"Early detection and treatment of subclinical lymphedema in patients with breast cancer","volume":"17","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"bib12-20230923","first-page":"5","article-title":"Lymphedema after treatment of breast cancer: a comprehensive review","volume":"4","year":"2019","journal-title":"J Unexplored Med Data"},{"issue":"12 Suppl American","key":"bib13-20230923","first-page":"2833","article-title":"The treatment of lymphedema","volume":"83","year":"1998","journal-title":"Cancer"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T05:43:04Z","timestamp":1695447784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003107"}},"subtitle":["A Multicenter Retrospective Analysis"],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000003107","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}